Inflammatory bowel disease can reduce ovarian reserve function in women: A systematic review and meta-analysis
review
OA: gold
CC0
Abstract
PURPOSE: We conducted a systematic review and meta-analysis to examine the role of inflammatory bowel disease (IBD) in ovarian reserve functions. METHODS: The PECO strategy was employed. Women of reproductive age (Population) and with IBD (Exposure) were compared with healthy women of reproductive age (Comparison) to evaluate the ovarian reserve function (Outcome). Two reviewers searched three databases as well as relevant gray literature. After following the PRISMA 2020 guidelines, RevMan 5.0 software and Newcastle-Ottawa Scale (NOS) scoring were used to analyze and summarize the data included in the studies. The protocol was registered on PROSPERO (CRD42021267804). RESULTS: The search yielded 367 studies, out of which 13 were selected for full-text evaluation, and finally, seven studies were included in our research. An analysis of ovarian reserve function in IBD women of reproductive age and healthy women revealed that the ovarian reserve function was lower in IBD women of reproductive age than in healthy women (P < .01, I2 = 81%); the ovarian reserve function was significantly lower in women with IBD in remission than in healthy women (P < .01, I2 = 0%), and ovarian reserve function was lower in IBD women of reproductive age taking thalidomide than in healthy women (P < .01, I2 = 18%). CONCLUSION: IBD could reduce ovarian reserve function in women of reproductive age, and patients should plan for conception as soon as possible under permissible conditions.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Müllerian hormone 2009
- Serum anti-Müllerian hormone levels are lower in reproductive-age women with Crohn's disease compared to healthy control women 2012
- Risk Factors Associated with Impaired Ovarian Reserve in Young Women of Reproductive Age with Crohn’s Disease 2020
- Ovarian reserve assessment in crohn patients of reproductive age 2021
References (40)
- IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Müllerian hormone via openalex
- Ovarian reserve assessment in crohn patients of reproductive age via openalex
- Risk Factors Associated with Impaired Ovarian Reserve in Young Women of Reproductive Age with Crohn’s Disease via openalex
- Serum anti-Müllerian hormone levels are lower in reproductive-age women with Crohn's disease compared to healthy control women via openalex
- doi:10.1016/j.fertnstert.2010.10.011 via openalex
- doi:10.1097/00042737-200012020-00014 via openalex
- doi:10.1016/j.fertnstert.2004.11.029 via openalex
- doi:10.1053/gast.2002.30345 via openalex
- doi:10.1016/s0020-7292(97)00088-x via openalex
- doi:10.1016/j.rbmo.2009.11.010 via openalex
- doi:10.1002/ibd.20884 via openalex
- doi:10.1016/j.cbi.2014.11.019 via openalex
- doi:10.1136/gut.2005.090316 via openalex
- doi:10.1136/gut.27.7.821 via openalex
- W6782920915 via openalex
- doi:10.1016/j.gtc.2016.02.006 via openalex
- doi:10.1093/humrep/det413 via openalex
- doi:10.1136/gut.25.1.52 via openalex
- doi:10.1016/j.fertnstert.2018.02.098 via openalex
- doi:10.1002/ibd.20839 via openalex
- doi:10.1093/ecco-jcc/jjaa191 via openalex
- doi:10.1080/00365529950173069 via openalex
- doi:10.1093/humrep/17.12.3065 via openalex
- doi:10.1016/j.gtc.2020.07.004 via openalex
- doi:10.1111/j.1600-0897.2008.00669.x via openalex
- doi:10.1016/j.fertnstert.2007.12.013 via openalex
- doi:10.1016/j.crohns.2012.09.010 via openalex
- doi:10.1016/j.crohns.2009.09.009 via openalex
- doi:10.1016/j.intimp.2015.02.036 via openalex
- doi:10.1097/01.mib.0000195385.19268.68 via openalex
- doi:10.1097/md.0000000000006540 via openalex
- doi:10.1177/1933719114549856 via openalex
- doi:10.1016/0016-5085(90)90617-a via openalex
- doi:10.3899/jrheum.131360 via openalex
- doi:10.1016/j.fertnstert.2008.08.123 via openalex
- doi:10.1093/humupd/dml034 via openalex
- doi:10.1093/rheumatology/kev124 via openalex
- doi:10.1007/bf02055604 via openalex
- doi:10.1002/ibd.21872 via openalex
- doi:10.1007/bf02052444 via openalex
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-05-13T19:29:48.425044+00:00
License: CC0
· commercial use OK